Electric Field Therapy: Results of the Phase 3 Trial (Novocure EF-14): A New Standard for the Treatment of Glioblastoma?

 

Related Videos (117)

In this brief presentation, neurosurgeon Steven Brem, MD, reviews Novo-TTF (tumor-treating fields), a modality for glioblastoma that involves the induction of a low intensity electric field within the brain to disrupt cell division during mitosis. Dr. Brem reports on the key study findings, and the known advantages of TTF, which include a significant prolongation of progression-free and overall survival, improved quality of life, absence of cognitive decline and seizures, and few side effects.

 

Penn PhysicianLink®

Penn PhysicianLink® is an exclusive program that helps all referring physicians connect with Penn Medicine. This comprehensive package of support services expedites and facilitates direct physician communication for patient consults, referrals and transfers.

Learn more about Penn PhysicianLink®